그리스 - 그리스어 - Εθνικός Οργανισμός Φαρμάκων

a.menarini industrie farmaceutiche riunite srl, italy via sette santi 3,, 50131, firenze, - netilmicin - inj.sol (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 200mg/2ml - netilmicin 200mg - netilmicin

사이프러스 - 그리스어 - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

recordati hellas pharmaceuticals sa (0000003596) 7 zoodochou pigis street, chalandri, athens, 15231 - lidocaine hydrochloride; tribenoside - rectal cream - lidocaine hydrochloride (0000073789) 2g; tribenoside (0010310324) 5g - other preparations, combinations

사이프러스 - 그리스어 - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

recordati hellas pharmaceuticals sa (0000003596) 7 zoodochou pigis street, chalandri, athens, 15231 - tribenoside; lidocaine - suppositories - tribenoside (0010310324) 400mg; lidocaine (0000137586) 40mg - other preparations, combinations

그리스 - 그리스어 - Εθνικός Οργανισμός Φαρμάκων

ΦΑΡΜΑΛΕΞ ΑΕΒΕ - pipazetate hydrochloride - ΕΠΙΚΑΛΥΜΕΝΟ ΔΙΣΚΙΟ - 20mg/tab - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

그리스 - 그리스어 - Εθνικός Οργανισμός Φαρμάκων

ΦΑΡΜΑΛΕΞ ΑΕΒΕ - pipazetate - ΠΟΣΙΜΕΣ ΣΤΑΓΟΝΕΣ, ΔΙΑΛΥΜΑ - 40mg/ml - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

그리스 - 그리스어 - Εθνικός Οργανισμός Φαρμάκων

ΦΑΡΜΑΛΕΞ ΑΕΒΕ - pipazetate - ΥΠΟΘΕΤΟ - 10mg/sup - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ

유럽 연합 - 그리스어 - EMA (European Medicines Agency)

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - Άλλοι αντινεοπλασματικοί παράγοντες - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

유럽 연합 - 그리스어 - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - Λέμφωμα, mantle-cell - Αντινεοπλασματικοί παράγοντες - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

그리스 - 그리스어 - Εθνικός Οργανισμός Φαρμάκων

cana Α.e. ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΗΡΑΚΛΕΙΟΥ 446, 14122 ΗΡΑΚΛΕΙΟ ΑΤΤΙΚΗΣ 2815502 - cetrimonium bromide; chlorhexidine gluconate - cut.sol (ΔΕΡΜΑΤΙΚΟ ΔΙΑΛΥΜΑ) - 15%+1,5% (w/v) - cetrimonium bromide 150mg; chlorhexidine gluconate 15mg - chlorhexidine, combinations